Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Preparation of antibody-loaded protein microbeads for pulmonary delivery via Shirasu porous glass membrane emulsification and freeze drying

Authors
Lee, Jae ChulLee, Eun ChaeLee, Ye NaHada, ShavronLee, Eun HeeKim, Nam AhKim, Ki HyunJeong, Seong Hoon
Issue Date
Jun-2024
Publisher
Editions de Sante
Keywords
Aerodynamic performance; Freeze drying; Membrane emulsification; Protein microbead
Citation
Journal of Drug Delivery Science and Technology, v.96, pp 1 - 13
Pages
13
Indexed
SCIE
SCOPUS
Journal Title
Journal of Drug Delivery Science and Technology
Volume
96
Start Page
1
End Page
13
URI
https://scholarworks.dongguk.edu/handle/sw.dongguk/21819
DOI
10.1016/j.jddst.2024.105600
ISSN
1773-2247
2588-8943
Abstract
Reversible protein precipitates (protein microbeads) have been developed using Shirasu porous glass (SPG) membrane emulsification. Microbeads have a mean size of a few micrometers (2–5 μm), and their formation is reversible upon rehydration. Their feasibility was examined as dry powders for pulmonary delivery of intravenous immunoglobulin (IVIG). Protein stability was investigated using size-exclusion chromatography, dynamic light scattering, circular dichroism, and fluorescence spectroscopy. Particle size and size distribution were determined by scanning electron microscope and laser diffraction. A next-generation impactor was used to measure the microbeads aerodynamic performance. Effects of trehalose as a stabilizer revealed that absence or presence of low trehalose (50 mM), the reversibility of the IVIG was 72.52 % or 89.00 %, respectively. On the other hand, it increased more than 98 % when trehalose concentration was more than 100 mM. However, trehalose crystallization occurred more than 300 mM and it was associated with reduced IVIG stability. SPG method had a critical role in obtaining uniform microbeads. Moreover, the freeze drying suppressed interparticle agglomeration, which enhanced the aerodynamic performance of microbeads with a fine particle fraction (<5 μm) value of 87.59 %. These findings suggested that microbeads with an optimized formulation and manufacturing process can be applied for pulmonary applications. © 2024 Elsevier B.V.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Pharmacy > Department of Pharmacy > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE